Clinical trials in Cuba
66 studies list at least one site in Cuba. 1 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-08-17.
Status
- Completed
- 52
- Status unknown
- 6
- Active, not recruiting
- 4
- Terminated
- 2
- Suspended
- 1
- Recruiting
- 1
Phase
- Phase 3
- 31
- Phase 2
- 25
- Phase 1
- 3
Most studied here
Who runs them
Catalysis SL (38) · Hoffmann-La Roche (4) · Mediterranea Medica S. L. (4) · International Center for Neurological Restoration, Cuba (3) · International Atomic Energy Agency (3) · University of Heidelberg Medical Center (2) · ARDEC Academy (2) · Eurofarma Laboratorios S.A. (1)
Studies
Recruiting first, then most recently updated. Showing 50 of 66 — search for more.
- Evaluation Glizigen® and Ocoxin®-Viusid® in High-grade Cervical Intraepithelial LesionsRecruitingNCT03549273Phase 2
- A Study to Describe the Diagnosis, Anti-Cancer Treatment and Clinical Outcome in Patients With Newly Diagnosed Breast Cancer in Latin AmericaCompletedNCT04158258
- An Observational Study to Evaluate the Real-World Clinical Management and Outcomes of ALK-Positive Advanced NSCLC Participants Treated With AlectinibActive, not recruitingNCT04764188
- Improving Disease Prevention Strategies by Integrating Socio-spatial Characterization of Human MobilityActive, not recruitingNCT06599970
- Cortical Lamina for Alveolar Ridge PreservationCompletedNCT07231874Not applicable
- A Study of the Efficacy and Safety of Atezolizumab Plus Chemotherapy for Patients With Early Relapsing Recurrent Triple-Negative Breast CancerCompletedNCT03371017Phase 3
- Subcrestal vs Juxtacrestal PRAMA Implants With Variable NecksActive, not recruitingNCT07107464Not applicable
- American Registry of Ambulatory or Acutely Decompensated Heart FailureCompletedNCT05295641
- Evaluation of Ocoxin®-Viusid® in Metastatic Colorectal AdenocarcinomaCompletedNCT03559543Phase 2
- Evaluation of Ocoxin®-Viusid® in Advanced Stomach Cancer and Gastric Esophagogastric JunctionCompletedNCT03549494Phase 2
- Study of Post-Op Adjuvant Concurrent Chemo-RT With or Without Nimotuzumab for Head & Neck CancerActive, not recruitingNCT00957086Phase 3
- A Study to Evaluate Patient Preference and Satisfaction of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Participants With HER2-Positive Early Breast CancerCompletedNCT03674112Phase 2
- Evaluation of Ocoxin-Viusid® in Advanced Pancreatic AdenocarcinomaCompletedNCT03717298Phase 2
- Evaluation of Ocoxin-Viusid® in Advanced or Metastatic Ovarian Epithelial CancerCompletedNCT03562897Phase 2
- ZIKAlliance Pregnant Women CohortCompletedNCT03188731
- ZIKAlliance Children Cohort (ZIKAllianceCH)CompletedNCT03393286
- Evaluation of Obex® in Overweight and ObesityCompletedNCT03541005Phase 3
- Comparison of Two Brief Mindfulness Intervention for Stress, Anxiety and Burnout in Mental Health ProfessionalsCompletedNCT03296254Not applicable
- Evaluation of the Attitude of Pre Menopausal Women With Breast Cancer Faced With the Risk of Fertility Loss Caused by ChemotherapyCompletedNCT02862990
- Tolerance to NeuroEPO in Parkinson DiseaseCompletedNCT04110678Phase 1/2
- Evaluation of Oncoxin-Viusid® in Cervical Cancer and Endometrial Adenocarcinoma.CompletedNCT03540407Phase 2
- Safety Study of Erythropoietin (EPO) in Parkinson's DiseaseCompletedNCT01010802Phase 1
- Resource Sparing Curative Radiotherapy for Locally Advanced Squamous Cell Cancer of the Head and Neck: The HYPNO TrialStatus unknownNCT02765503Not applicable
- Evaluation of Oncoxin-Viusid® in Prostate CancerCompletedNCT03543670Phase 2
- Alzer® and Diamel® to Prevent Severe Diabetes Macular EdemaCompletedNCT03533478Phase 2
- Efficacy of VIUSID® Plus GLIZIGEN® in Patients With Papilloma Virus EsophagealCompletedNCT03584308Phase 2
- Evaluation of DIAMEL® Combined With Insulin in Diabetic Foot UlcerCompletedNCT03583593Phase 2
- Evaluation of Ocoxin®-Viusid® in Breast CancerCompletedNCT03576521Phase 2
- Evaluation of Oncoxin-Viusid® in Head and Neck CancerCompletedNCT03541772Phase 2
- Evaluation of Oncoxin-Viusid® in Cutaneous MelanomaCompletedNCT03541148Phase 2
- Effects of Obex in Overweight and Obese PatientsCompletedNCT02145442Phase 2/3
- Immunotherapy With Racotumomab in Advanced Lung CancerStatus unknownNCT01460472Phase 3
- Initiative for Patient Outcomes in Dialysis - Peritoneal Dialysis (PD) (IPOD-PD Study)CompletedNCT01285726
- Nimotuzumab and Radiotherapy in Pediatric Patients With GliomaCompletedNCT01145170Phase 2
- Mifepristone 2.5, 5, 10 mg Versus Placebo in the Treatment of EndometriosisCompletedNCT02271958Phase 2/3
- Mifepristone 10 or 5 mg for 6 Months to Treat Uterine FibroidsCompletedNCT00886873Phase 2/3
- Mifepristone to Treat Uterine FibroidsTerminatedNCT01786226Phase 2/3
- Renalof in the Treatment of Elderly Patients With GallstonesCompletedNCT01099319Phase 3
- Glizigen-Viudid-External Anogenital Warts in Children and AdolescentsCompletedNCT01111344Phase 3
- Efficacy of Nutritional Supplement VIUSID/ALZER in Patients With Parkinson's DiseaseCompletedNCT01016470Phase 3
- Antioxidant and Immunomodulator Properties of Viusid in Patients With Chronic Hepatitis CCompletedNCT00778843Phase 3
- Efficacy and Safety of ONCOXIN in Patients With Breast Fibrocystic DiseaseCompletedNCT00967681Phase 3
- Melanil in the Treatment of MelasmaCompletedNCT01001624Phase 3
- Diamel in the Treatment of Polycystic Ovary SyndromeCompletedNCT01051024Phase 3
- Efficacy and Safety of Diamel in Patients With Nonalcoholic SteatohepatitisCompletedNCT00820651Phase 3
- Resource-Sparing Curative Treatment for Rectal CancerStatus unknownNCT01459328Phase 3
- Resource-sparing Post-mastectomy Radiotherapy in Breast CancerStatus unknownNCT01452672Phase 3
- A Study of Nimotuzumab in Combination With Radiation Therapy in Patients With Brain MetastasesTerminatedNCT00872482Phase 2
- Efficacy of Oncoxin Plus Viusid in the Treatment of Rheumatoid ArthritisCompletedNCT00969527Phase 3
- Diamel in the Treatment of Type 2 Diabetic Patients Receiving Insulin TherapyCompletedNCT00994266Phase 3